{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:56:06Z","timestamp":1761393366449},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s11010-005-4441-x","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T10:37:06Z","timestamp":1123843026000},"page":"219-225","source":"Crossref","is-referenced-by-count":21,"title":["Inhibition of secretory phospholipase A2 enzyme by bilirubin: A new role as endogenous anti-inflammatory molecule"],"prefix":"10.1007","volume":"276","author":[{"given":"Noor Mohamed","family":"Jameel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte M.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix J.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Veerabasappa","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bannikuppe S.","family":"Vishwanath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"(2 Pt 2)","key":"4441_CR1","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-7","volume":"161","author":"EA Dennis","year":"2000","unstructured":"Dennis EA: Phospholipase A2 in eicosanoid generation. Am J Respir Crit Care Med 161(2 Pt 2): S32\u2013S35, 2000","journal-title":"Am J Respir Crit Care Med"},{"key":"4441_CR2","first-page":"159","volume":"2","author":"G Bereziat","year":"1990","unstructured":"Bereziat G, Etienne J, Kokkinidis M, Olivier JL, Pernas P: New trends in mammalian non-pancreatic phospholipase A2 research. J Lipid Mediat 2: 159\u2013172, 1990","journal-title":"J Lipid Mediat"},{"key":"4441_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1388-1981(00)00105-0","volume":"1488","author":"Six DA","year":"2000","unstructured":"Six DA, Dennis EA: The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 1488: 1\u201319, 2000","journal-title":"Biochim Biophys Acta"},{"key":"4441_CR4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2174\/1566524013363258","volume":"1","author":"L Touqui","year":"2001","unstructured":"Touqui L, Alaoui-El-Azher M: Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med 1: 739\u2013754, 2001","journal-title":"Curr Mol Med"},{"key":"4441_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.pharmtox.39.1.175","volume":"39","author":"J Balsinde","year":"1999","unstructured":"Balsinde J, Balboa MA, Insel PA, Dennis EA: Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol 39: 175\u2013189, 1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4441_CR6","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.toxicon.2003.11.006","volume":"42","author":"CF Teixeira","year":"2003","unstructured":"Teixeira CF, Landucci EC, Antunes E, Chacur M, Cury Y: Inflammatory effects of snake venom myotoxic phospholipases A2. Toxicon 42: 947\u2013962, 2003","journal-title":"Toxicon"},{"key":"4441_CR7","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.4049\/jimmunol.146.11.3904","volume":"146","author":"JS Bomalaski","year":"1991","unstructured":"Bomalaski JS, Lawton P, Browning JL: Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. J Immunol 146: 3904\u20133910, 1991","journal-title":"J Immunol"},{"key":"4441_CR8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF00914317","volume":"12","author":"BS Vishwanath","year":"1988","unstructured":"Vishwanath BS, Fawzy AA, Franson RC: Inhibition of human non-pancreatic phospholipase A2 by retenoids and falvonoids. Mechanism of action. Inflammation 12: 549\u2013561, 1988","journal-title":"Mechanism of action. Inflammation"},{"key":"4441_CR9","first-page":"129","volume":"11","author":"BM Weichman","year":"1989","unstructured":"Weichman BM, Berkenkopf JW, Marshall LA: Phospholipase A2-induced pleural inflammation in rats. Int J Tissue React 11: 129\u2013136, 1989","journal-title":"Int J Tissue React"},{"key":"4441_CR10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","volume":"235","author":"R Stocker","year":"1987","unstructured":"Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043\u20131046, 1987","journal-title":"Science"},{"key":"4441_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/abbi.1998.0584","volume":"352","author":"M Minetti","year":"1998","unstructured":"Minetti M, Mallozzi C, Di Stasi AM, Pietraforte D: Bilirubin is an effective antioxidant of peroxynitrite-mediated protein oxidation in human blood plasma. Arch Biochem Biophys 352: 165\u2013174, 1998","journal-title":"Arch Biochem Biophys"},{"key":"4441_CR12","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/clinchem\/46.11.1723","volume":"46","author":"M Mayer","year":"2000","unstructured":"Mayer M: Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 46: 1723\u20131727, 2000","journal-title":"Clin Chem"},{"key":"4441_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-4165(93)90013-X","volume":"1158","author":"T Nakagami","year":"1993","unstructured":"Nakagami T, Toyomura K, Kinoshita T, Morisawa S: A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158: 189\u2013193, 1993","journal-title":"Biochim Biophys Acta"},{"key":"4441_CR14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-4613-0651-1_15","volume-title":"Biochemistry, Molecular Biology, and Physiology of Phospholipase A2 and its Regulatory Factors","author":"R Franson","year":"1990","unstructured":"Franson R, Raghupathi R, Fry M, Saal J, Vishwanath B, Gosh SS, Rosenthal MD: Inhibition of human phospholipase A2 by cis-unsaturated fatty acids and oligomers of prostaglandin B1. In: A.B. Mukherjee. (ed). Biochemistry, Molecular Biology, and Physiology of Phospholipase A2 and its Regulatory Factors, Plenum press, New york, 1990, p 219"},{"key":"4441_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0041-0101(89)90136-0","volume":"27","author":"S Kasturi","year":"1989","unstructured":"Kasturi S, Gowda TV: Purification and characterization of a major phospholipase A2 from Russell\u2019s viper (Vipera russelli) venom. Toxicon 27: 229\u2013237, 1989","journal-title":"Toxicon"},{"key":"4441_CR16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0041-0101(97)00097-4","volume":"36","author":"LM Rudrammaji","year":"1998","unstructured":"Rudrammaji LM, Gowda TV: Purification and characterization of three acidic, cytotoxic phospholipases A2 from Indian cobra (Naja naja naja) venom. Toxicon 36: 921\u2013932, 1998","journal-title":"Toxicon"},{"key":"4441_CR17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0005-2760(72)90008-2","volume":"260","author":"P Patriarca","year":"1972","unstructured":"Patriarca P, Beckerdite S, Elsbach P: Phospholipases and phospholipid turnover in Escherichia coli spheroplasts. Biochim Biophys Acta 260: 593\u2013600, 1972","journal-title":"Biochim Biophys Acta"},{"key":"4441_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1172\/JCI118801","volume":"98","author":"BS Vishwanath","year":"1996","unstructured":"Vishwanath BS, Frey FJ, Escher G, Reichen J, Frey BM: Liver cirrhosis induces renal and liver phospholipase A2 activity in rats. J Clin Invest 98: 365\u2013371, 1996","journal-title":"J Clin Invest"},{"key":"4441_CR19","unstructured":"www.embl-heidelberg.de\/~andrade\/k2dfaq.html."},{"key":"4441_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4684-0886-7_10","volume-title":"Animal Plant and Microbial Toxins, Vol 1","author":"MM Yamakawa","year":"1976","unstructured":"Yamakawa MM, Hokama NZ: Fractionation of Sakishima habu (T. elegans) venom and lethal hemorrhagic and edema forming activity of the fractions. In: A. Ohsaka, K. Hayashi and Y. Sawai (eds). Animal Plant and Microbial Toxins, Vol 1, Plenum press, New york, 1976, p 97"},{"key":"4441_CR21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0898-6568(02)00144-4","volume":"15","author":"S Chakraborti","year":"2003","unstructured":"Chakraborti S: Phospholipase A(2) isoforms: a perspective. Cell Signal 15: 637\u2013665, 2003","journal-title":"Cell Signal"},{"key":"4441_CR22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0003-9861(02)00527-1","volume":"408","author":"M Deepa","year":"2002","unstructured":"Deepa M, Veerabasappa Gowda T: Purification and characterization of a glycoprotein inhibitor of toxic phospholipase from Withania somnifera. Arch Biochem Biophys 408: 42\u201350, 2002","journal-title":"Arch Biochem Biophys"},{"key":"4441_CR23","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0006-2952(92)90381-R","volume":"44","author":"W Pruzanski","year":"1992","unstructured":"Pruzanski W, Greenwald RA, Street IP, Laliberte F, Stefanski E, Vadas P: Inhibition of enzymatic activity of phospholipases A2 by minocycline and doxycycline. Biochem Pharmacol 44: 1165\u20131170, 1992","journal-title":"Biochem Pharmacol"},{"key":"4441_CR24","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/0006-2952(87)90512-0","volume":"36","author":"J Chang","year":"1987","unstructured":"Chang J, Musser JH, McGregor H: Phospholipase A2: function and pharmacological regulation. Biochem Pharmacol 36: 2429\u20132436, 1987","journal-title":"Biochem Pharmacol"},{"key":"4441_CR25","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0021-9258(19)75694-4","volume":"262","author":"FF Davidson","year":"1987","unstructured":"Davidson FF, Dennis EA, Powell M, Glenney JR Jr: Inhibition of phospholipase A2 by \u201clipocortins\u201d and calpactins. An effect of binding to substrate phospholipids. J Biol Chem 262: 1698\u20131705, 1987","journal-title":"J Biol Chem"},{"issue":"(3\u20134)","key":"4441_CR26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF01965048","volume":"25","author":"AA Fawzy","year":"1988","unstructured":"Fawzy AA, Vishwanath BS, Franson RC: Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action. Agents Actions 25(3\u20134): 394\u2013400, 1988","journal-title":"Agents Actions"},{"key":"4441_CR27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4757-2508-7_3","volume-title":"Circular Dichroism and the Conformational Analysis of Biomolecules","author":"SY Venyaminov","year":"1996","unstructured":"Venyaminov SY, Yang JT: Determination of protein secondary structure. In: G.D. Fasman (ed). Circular Dichroism and the Conformational Analysis of Biomolecules, Plenum Press, New York, 1996, p 69"},{"issue":"2","key":"4441_CR28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0141-8130(00)00117-3","volume":"27","author":"Lin YH","year":"2000","unstructured":"Lin YH, Huang WN, Lee SC, Wu WG: Heparin reduces the alpha-helical content of cobra basic phospholipase A(2) and promotes its complex formation. Int J Biol Macromol 27(2): 171\u2013176, 2000","journal-title":"Int J Biol Macromol"},{"key":"4441_CR29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0041-0101(87)90156-5","volume":"25","author":"BS Vishwanath","year":"1987","unstructured":"Vishwanath BS, Appu Rao AG, Gowda TV: Interaction of phospholipase A2 from Vipera russelli venom with aristolochic acid: a circular dichroism study. Toxicon 25: 939\u2013946, 1987","journal-title":"Toxicon"},{"key":"4441_CR30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/BF00914317","volume":"12","author":"BS Vishwanath","year":"1988","unstructured":"Vishwanath BS, Fawzy AA, Franson RC: Edema inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid. Inflammation 12: 549\u2013561, 1988","journal-title":"Inflammation"},{"key":"4441_CR31","first-page":"PL35","volume":"66","author":"A Sala","year":"2000","unstructured":"Sala A, Recio MC, Giner RM, Manez S, Rios JL: Anti-phospholipase A2 and anti-inflammatory activity of Santolina chamaecyparissus. Life Sci 66: PL35\u2013PL40, 2000","journal-title":"Life Sci"},{"key":"4441_CR32","first-page":"1223","volume":"47","author":"M Miyashita","year":"2000","unstructured":"Miyashita M, Onda M, Nomura T, Matsutani T, Tsuchiya Y, Sasajima K: Inhibited serum phospholipase A2 activity in hyperbilirubinemia. Hepatogastroenterology 47: 1223\u20131226, 2000","journal-title":"Hepatogastroenterology"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-005-4441-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-005-4441-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-005-4441-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T22:13:26Z","timestamp":1706480006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-005-4441-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":32,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["4441"],"URL":"https:\/\/doi.org\/10.1007\/s11010-005-4441-x","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}